The First Human Immunotherapy Trial with a Viral Oncolysate Vaccine Induced a Large Number of Granular Lymphocytes Later Recognized as 'Natural Killer Cells'

Abstract

Sinkovics. Int J Virol AIDS 2019, 6:049 • Page 1 of 4 • Citation: Sinkovics JG (2019) The First Human Immunotherapy Trial with a Viral Oncolysate Vaccine Induced a Large Number of Granular Lymphocytes Later Recognized as ‘Natural Killer Cells’. Int J Virol AIDS 6:049. doi.org/10.23937/2469-567X/1510049 Accepted: March 14, 2019: Published: March 16, 2019 Copyright: © 2019 Sinkovics JG. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. The First Human Immunotherapy Trial with a Viral Oncolysate Vaccine Induced a Large Number of Granular Lymphocytes Later Recognized as ‘Natural Killer Cells’